Cite

HARVARD Citation

    Rubin, D. et al. (2021). Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis. Therapeutic advances in gastroenterology. p. . [Online]. 
  
Back to record